First-in-human study of [68Ga]Ga-AAZTA-093, a novel PSMA-targeting agent, in patients with prostate cancer

被引：0
|
作者：
Wang, G. [1 ]
Jin, W. [2 ]
Luo, Y. [2 ]
Wang, R. [2 ]
Zhu, L. [2 ]
Kung, H. [3 ]
Miao, W. [1 ]
机构：
[1] Fujian Med Univ, Affiliated Hosp 1, Fuzhou, Peoples R China
[2] Beijing Normal Univ, Beijing, Peoples R China
[3] Univ Penn, Philadelphia, PA USA
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2024年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EP-0281
引用
收藏
页码：S542 / S542
页数：1
相关论文
共 50 条
  • [21] MR PET scan with 68GA PSMA in prostate cancer
    Lo, R.
    Lo, C.
    Chan, J.
    Cheung, W.
    Lo, G.
    INTERNATIONAL JOURNAL OF UROLOGY, 2017, 24 : 84 - 85
  • [22] MR PET scan with 68Ga PSMA in prostate cancer
    Lo, R. K.
    Lo, C. S.
    Chan, J. K.
    Cheung, W. S.
    Lo, G. G.
    BJU INTERNATIONAL, 2017, 119 : 7 - 7
  • [23] Predictor of 68Ga PSMA PET/CT positivity in patients with prostate cancer
    Soydal, Cigdem
    Urun, Yuksel
    Suer, Evren
    Nak, Demet
    Ozkan, Elgin
    Kucuk, Nuriye O.
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 64 (02): : 226 - 230
  • [24] [68Ga]Ga-PSMA-11: The First FDA-Approved 68Ga-Radiopharmaceutical for PET Imaging of Prostate Cancer
    Hennrich, Ute
    Eder, Matthias
    PHARMACEUTICALS, 2021, 14 (08)
  • [25] Design, preclinical evaluation, and first-in-human PET study of [68Ga]Ga-PSFA-01: a PSMA/FAP heterobivalent tracer
    Wang, Xinlin
    Zhang, Xiaoyang
    Zhang, Xiaojun
    Guan, Lili
    Gao, Xi
    Xu, Lu
    Pang, Hua
    Du, Jin
    Zhang, Jinming
    Cui, Mengchao
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2025, 52 (03) : 1166 - 1176
  • [26] A prospective comparative study of [68Ga]Ga-RM26 and [68Ga]Ga-PSMA-617 PET/CT imaging in suspicious prostate cancer
    Gao, Xiaomei
    Tang, Yongxiang
    Chen, Minfeng
    Li, Jian
    Yin, Hongling
    Gan, Yu
    Zu, Xiongbin
    Cai, Yi
    Hu, Shuo
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (07) : 2177 - 2187
  • [27] A prospective comparative study of [68Ga]Ga-RM26 and [68Ga]Ga-PSMA-617 PET/CT imaging in suspicious prostate cancer
    Xiaomei Gao
    Yongxiang Tang
    Minfeng Chen
    Jian Li
    Hongling Yin
    Yu Gan
    Xiongbin Zu
    Yi Cai
    Shuo Hu
    European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50 : 2177 - 2187
  • [28] Initial clinical study results of 68Ga/177Lu-NYM032, a new generation of PSMA-targeting theranostic radiopharmaceuticals, in patients with metastatic prostate cancer
    He, H.
    Wang, Y.
    Mi, Y.
    Yan, C.
    Fang, P.
    Eng, W.
    Fu, H.
    Yu, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S180 - S181
  • [29] A novel PSMA-targeting tracer with highly negatively charged linker demonstrates decreased salivary gland uptake in mice compared to [68Ga]Ga-PSMA-11
    Steve S. Huang
    Frank P. DiFilippo
    Daniel J. Lindner
    Warren D. Heston
    EJNMMI Radiopharmacy and Chemistry, 9
  • [30] Application of [68Ga]PSMA PET/CT in Diagnosis and Management of Prostate Cancer Patients
    Dadgar, Habibollah
    Emami, Farshad
    Norouzbeigi, Nasim
    Vafaee, Manouchehr Seyedi
    Jafari, Esmail
    Gholamrezanezhad, Ali
    Assadi, Majid
    Ahmadzadehfar, Hojjat
    MOLECULAR IMAGING AND BIOLOGY, 2020, 22 (04) : 1062 - 1069
12345